WuXi PharmaTech Co., Ltd.: Q1 Revenues Up 23%; Earnings Flat

WuXi PharmaTech, China's largest CRO/CMO, reported 2015 Q1 earnings grew 23% from the year earlier to $180 million, but GAAP net income was flat at $17.8 million. Dr. Ge Li, WuXi's Founder, President and CEO, blamed higher labor costs in China and investments in business expansion for lower margins. In the conference call, Dr. Li added that WuXi is talking with partners about several co-development projects and also contemplating a number of acquisitions.

Help employers find you! Check out all the jobs and post your resume.

Back to news